Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors.
MedMen
Post IPO Equity • Culver City, United States
Amneal Pharmaceuticals
Post IPO Equity • Bridgewater, United States
PTC Therapeutics
Post IPO Equity • South Plainfield, United States
Alnylam Pharmaceuticals
Post IPO Equity • Cambridge, United States
Signature Bank
Post IPO Equity • New York, United States
Seattle Genetics
Post IPO Equity • Bothell, United States
Esperion Therapeutics
Post IPO Equity • Ann Arbor, United States
Cornerstone
Post IPO Equity • Santa Monica, United States
Aldeyra Therapeutics
Post IPO Equity • Lexington, United States
Ra Pharmaceuticals
Post IPO Equity • Cambridge, United States
Intra-Cellular Therapies
Post IPO Equity • New York, United States
Real
Post IPO Equity • New York, United States